| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.51▼ | 1.49▲ | 1.66▼ |
| MA10 | 1.51▼ | 1.51▼ | 1.48▲ | 1.56▼ | 1.88▼ |
| MA20 | 1.48▲ | 1.48▲ | 1.48▲ | 1.68▼ | 2.27▼ |
| MA50 | 1.48▲ | 1.53▼ | 1.55▼ | 1.89▼ | 3.95▼ |
| MA100 | 1.52▼ | 1.60▼ | 1.66▼ | 2.36▼ | 5.23▼ |
| MA200 | 1.57▼ | 1.79▼ | 1.92▼ | 3.23▼ | 4.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.007▲ | 0.011▲ | -0.013▼ | 0.048▲ |
| RSI | 50.767▲ | 48.620▼ | 47.635▼ | 37.065▼ | 34.337▼ |
| STOCH | 22.914 | 66.546 | 79.558 | 18.122▼ | 28.301 |
| WILL %R | -76.923▼ | -32.258 | -32.258 | -77.143▼ | -91.045▼ |
| CCI | -66.582 | 23.222 | 42.593 | -104.872▼ | -110.019▼ |
| ▲ GAP | $ABUS Open Gap Up %2 | Set Alert |
|
Tuesday, August 06, 2019 06:49 AM
WARMINSTER, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr.
|
|
Monday, August 05, 2019 05:08 PM
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2019 Results Earnings Conference Call August 5, 2019 8:45 AM ET Company Participants Pam Murphy - IR Consultant William Collier - President ...
|
|
Monday, August 05, 2019 04:37 AM
Arbutus Biopharma (NASDAQ:ABUS): Q2 GAAP EPS of -$0.46 misses by $0.08. Revenue of $0.7M (-41.7% Y/Y) misses by $0.09M.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/08/19 | 1.45 | 1.54 | 1.45 | 1.50 | 141,500 |
| 15/08/19 | 1.49 | 1.58 | 1.38 | 1.42 | 137,100 |
| 14/08/19 | 1.53 | 1.65 | 1.45 | 1.47 | 209,800 |
| 13/08/19 | 1.51 | 1.57 | 1.46 | 1.55 | 207,906 |
| 12/08/19 | 1.64 | 1.68 | 1.51 | 1.51 | 167,000 |
| 09/08/19 | 1.64 | 1.70 | 1.61 | 1.65 | 177,300 |
| 08/08/19 | 1.62 | 1.645 | 1.61 | 1.635 | 215,479 |
| 07/08/19 | 1.63 | 1.65 | 1.575 | 1.615 | 69,286 |
| 06/08/19 | 1.62 | 1.68 | 1.57 | 1.64 | 120,283 |
| 05/08/19 | 1.67 | 1.76 | 1.55 | 1.60 | 207,900 |
|
|
||||
|
|
||||
|
|